| 000 | 01594 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250511214819.0 | ||
| 264 | 0 | _c19910426 | |
| 008 | 199104s 0 0 eng d | ||
| 022 | _a0360-4012 | ||
| 024 | 7 |
_a10.1002/jnr.490270409 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRinne, J O | |
| 245 | 0 | 0 |
_aPET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease. _h[electronic resource] |
| 260 |
_bJournal of neuroscience research _cDec 1990 |
||
| 300 |
_a494-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAntipsychotic Agents |
| 650 | 0 | 4 |
_aBenzazepines _xanalogs & derivatives |
| 650 | 0 | 4 | _aCarbon Radioisotopes |
| 650 | 0 | 4 |
_aCerebellum _xmetabolism |
| 650 | 0 | 4 |
_aCorpus Striatum _xdiagnostic imaging |
| 650 | 0 | 4 | _aDopamine Antagonists |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorine Radioisotopes |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aParkinson Disease _xdiagnostic imaging |
| 650 | 0 | 4 | _aRaclopride |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xmetabolism |
| 650 | 0 | 4 | _aSalicylamides |
| 650 | 0 | 4 | _aTomography, Emission-Computed |
| 700 | 1 | _aLaihinen, A | |
| 700 | 1 | _aNågren, K | |
| 700 | 1 | _aBergman, J | |
| 700 | 1 | _aSolin, O | |
| 700 | 1 | _aHaaparanta, M | |
| 700 | 1 | _aRuotsalainen, U | |
| 700 | 1 | _aRinne, U K | |
| 773 | 0 |
_tJournal of neuroscience research _gvol. 27 _gno. 4 _gp. 494-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jnr.490270409 _zAvailable from publisher's website |
| 999 |
_c1988101 _d1988101 |
||